World · India Bureau
Artemis Medicare rallies 14% on strong trading volume; analyst initiates coverage
Healthcare services provider Artemis Medicare surged 14% on robust trading volumes, extending its gains to 87% from April lows. InCred Equities has initiated coverage with a positive outlook on the company's expansion trajectory.
LSN India ·
Shares of Artemis Medicare climbed sharply during intraday trading, with volumes significantly exceeding average levels. The surge extended recent momentum, with the stock having recovered substantially from its April lows this year.
InCred Equities has initiated research coverage on the healthcare services company with a 'Buy' recommendation, setting a target price of ₹437 per share. The brokerage's positive stance reflects confidence in the company's operational expansion strategy and financial performance trajectory.
The analyst's bullish view is anchored on expectations of healthy earnings growth driven by the company's planned addition of operational beds. Expansion of bed capacity is viewed as a key driver of revenue growth and operational efficiency for healthcare service providers in India.
The stock's significant recovery from April levels signals renewed investor interest in Artemis Medicare, suggesting market confidence in the healthcare sector's growth prospects. The combination of strong trading activity and analyst support underscores growing institutional attention to the company's expansion narrative.